Vertex Executive and Leadership Team

Reshma Kewalramani, the President & Chief Executive Officer at Vertex, directs the overarching corporate strategy and scientific vision. Overseeing the development of transformative medicines for cystic fibrosis and other genetic disorders, the President & Chief Executive Officer ensures alignment between research initiatives and patient needs. This leadership role involves managing complex biotechnology portfolios while driving long-term growth across international markets. By fostering a culture of scientific excellence, Reshma Kewalramani directly impacts the ability of the organization to address serious diseases with significant unmet medical needs. Ultimately, Kewalramani secures the future of the company through disciplined investment in high-impact research programs and strategic partnerships with healthcare providers, specialty pharmacies, and hospitals worldwide, ensuring that innovative therapies reach patients efficiently and effectively across diverse global regions.

Gina LaCorcia, the Vice President, Chief of Staff To the Chief Executive Officer and Head of the Disease Strategy Team Program Office at Vertex, coordinates executive priorities and disease-specific research roadmaps. Managing the integration of cross-functional teams, the Vice President, Chief of Staff To the Chief Executive Officer and Head of the Disease Strategy Team Program Office ensures that strategic objectives remain synchronized with the broader mission of developing therapies for sickle cell disease and other genetic conditions. This role involves facilitating communication between senior leadership and research departments to accelerate drug development cycles. By optimizing operational workflows, Gina LaCorcia directly supports the execution of complex medical programs. Ultimately, LaCorcia drives organizational efficiency, ensuring that the company maintains a competitive edge in the biotechnology sector while addressing critical health challenges through rigorous scientific inquiry and strategic resource allocation across all internal research divisions.

Adila Crimi, the Head To of Cell & Gene Therapy Research Chief of Staff at Vertex, manages the operational framework for advanced genetic research programs. Overseeing the laboratory resources and scientific talent dedicated to type 1 diabetes and myotonic dystrophy, the Head To of Cell & Gene Therapy Research Chief of Staff ensures that research milestones align with corporate development goals. This leadership position involves coordinating with external distributors and research partners to advance the pipeline of innovative therapies. By streamlining the transition from discovery to clinical application, Adila Crimi directly impacts the speed at which new treatments reach patients. Ultimately, Crimi maintains the integrity of the research pipeline, ensuring that the company continues to pioneer breakthroughs in genetic medicine while upholding the highest standards of scientific rigor and operational excellence within the biotechnology industry.

Moira Scanlon, the Director, Chief of Staff - Global Commercial Strategy at Vertex, architects the commercialization plans for the company's portfolio of medicines. Overseeing market access and distribution strategies, the Director, Chief of Staff - Global Commercial Strategy ensures that therapies for transfusion-dependent beta thalassemia and other conditions reach patients through hospitals and specialty pharmacies. This role involves analyzing global market trends to inform pricing and distribution models that maximize patient access. By aligning commercial efforts with clinical data, Moira Scanlon directly supports the revenue growth of the organization. Ultimately, Scanlon drives the successful launch and sustained market presence of new products, ensuring that the company effectively serves patients across diverse geographic regions while maintaining strong relationships with healthcare providers and distributors to support the long-term commercial viability of the entire product portfolio.

Rashmi Sarnaik, the Director, Chief of Staff To the Head of Medical Affairs at Vertex, manages the strategic engagement between the company and the medical community. Overseeing the dissemination of clinical data and medical education, the Director, Chief of Staff To the Head of Medical Affairs ensures that healthcare providers possess the necessary information to utilize therapies for acute pain and other serious diseases effectively. This leadership role involves coordinating medical advisory boards and supporting clinical research initiatives that validate the efficacy of the product portfolio. By fostering transparent communication with the medical field, Rashmi Sarnaik directly impacts the adoption and clinical success of new treatments. Ultimately, Sarnaik strengthens the reputation of the company as a trusted partner in healthcare, ensuring that medical affairs activities support the broader mission of improving patient outcomes through evidence-based medicine.

Sazzad Hussain, the Senior Principal Scientist and Chief Revenue Officer Monitor and Associate Director at Vertex, evaluates the financial performance of research programs and monitors revenue streams. Overseeing the analytical frameworks that track the economic impact of drug development, the Senior Principal Scientist and Chief Revenue Officer Monitor and Associate Director ensures that scientific investments yield sustainable financial returns. This role involves bridging the gap between laboratory research and commercial profitability to optimize resource allocation. By providing data-driven insights into revenue potential, Sazzad Hussain directly supports the financial health of the organization. Ultimately, Hussain secures the fiscal stability of the company, ensuring that research programs remain aligned with market demands and that the organization maintains the necessary capital to continue developing life-changing medicines for patients suffering from serious genetic disorders and other unmet medical needs.

Olivia Green, the Director, Chief of Staff, U. S. Commercial at Vertex, executes the commercial strategy within the North American market. Overseeing the operational deployment of sales and marketing initiatives, the Director, Chief of Staff, U. S. Commercial ensures that the company effectively reaches patients and healthcare providers across the region. This leadership role involves coordinating with regional distributors and specialty pharmacies to streamline the delivery of medicines for cystic fibrosis and other serious conditions. By optimizing the commercial infrastructure, Olivia Green directly impacts the market penetration and patient reach of the company. Ultimately, Green drives regional growth, ensuring that the organization maintains a strong competitive position in the United States while delivering essential therapies to patients who rely on the company for life-sustaining medical solutions and consistent access to innovative treatments.

Dionna Di Pierro, the Senior Director, Chief of Staff To the Senior Vice President of Quality at Vertex, manages the quality assurance and regulatory compliance frameworks. Overseeing the manufacturing standards and safety protocols, the Senior Director, Chief of Staff To the Senior Vice President of Quality ensures that all medicines meet the highest levels of efficacy and safety before reaching patients. This role involves coordinating with internal production teams and external regulatory bodies to maintain compliance across all manufacturing sites. By upholding rigorous quality standards, Dionna Di Pierro directly impacts the reliability and safety of the product portfolio. Ultimately, Di Pierro protects the reputation of the company, ensuring that every therapy produced adheres to strict global standards, thereby fostering trust among healthcare providers and patients who depend on the consistent quality of the company's life-saving medical products.

Stephanie Franklin, the Senior VP & Chief Human Resources Officer at Vertex, directs the talent acquisition and organizational development strategies. Overseeing the recruitment of top-tier scientific and commercial talent, the Senior VP & Chief Human Resources Officer ensures that the company maintains a workforce capable of driving innovation in biotechnology. This leadership role involves designing programs that foster employee engagement, professional growth, and a culture of inclusion. By aligning human capital with the strategic goals of the organization, Stephanie Franklin directly impacts the ability of the company to execute its research and commercial missions. Ultimately, Franklin secures the long-term success of the organization by building a high-performing team that remains dedicated to the mission of developing medicines for serious diseases, ensuring that the company attracts and retains the best minds in the industry.

Stephanie Franklin, the Senior VP & Chief Human Resources Officer, Vertex Pharmaceuticals at Vertex, manages the global human resources operations and organizational culture. Overseeing the implementation of performance management systems and leadership development initiatives, the Senior VP & Chief Human Resources Officer, Vertex Pharmaceuticals ensures that the company remains agile and responsive to the evolving needs of the biotechnology sector. This role involves coordinating with department heads to identify talent gaps and implement training programs that support the development of new therapies for genetic disorders. By cultivating a supportive work environment, Stephanie Franklin directly impacts the productivity and innovation of the entire organization. Ultimately, Franklin drives the operational effectiveness of the company, ensuring that the workforce remains motivated and equipped to tackle the complex challenges associated with developing and commercializing medicines for patients with significant unmet medical needs.